Trials Sponsors Conditions Drugs Pricing

Conditions

Acute Lymphoblastic Leukemia ALL, Childhood

Outcome Measures

Primary Outcomes (2)

Implicit Association Bias Testing
Participants' implicit associations with exercise will be measured using the Personalized Single-Category Implicit Association test (PSC-IAT).
Before and after Cardiovascular Stress Testing at Baseline
Behavioral Regulation of Exercise Questionnaire (BREQ-2):
The Behavioral Regulation of Exercise Questionnaire (BREQ-2) will be administered once to participants in this study to assess trait-level affective motivation.
Before and after Cardiovascular Stress Testing at Baseline

Interventions

Affective Response to ExerciseOther

Participants will perform a total of three trials of a cognitive task before and after their scheduled SJLIFE cardiovascular stress testing. Participants will then be asked to participate in a qualitative interview about the cognitive task tool and body sensations and emotions experienced during exercise.

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age18 Years - 39 Years

Sexall

Healthy VolunteersNo

Age GroupsAdult (18-64)

Sampling MethodNon-Probability Sample

Study Population

The study population will include survivors from the SJLIFE cohort from the ALL diagnostic group (treated without cranial radiation therapy (CRT). This group was chosen because of the prevalence of ALL in childhood cancer diagnoses, and to attempt to prevent potential difficulties with the cognitive task due to cognitive impairment from CRT.

You may qualify if:

Participants enrolled in St. Jude Lifetime Cohort (SJLIFE) aged 18-39 years at completion of on campus visit

Sponsors & Collaborators

St. Jude Children's Research Hospital
Otherlead

Study Sites (1)

St. Jude Children's Research Hospital

Memphis, Tennessee, 38105, United States

MeSH Terms

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Condition Hierarchy (Ancestors)

Leukemia, LymphoidLeukemiaNeoplasms by Histologic TypeNeoplasmsHematologic DiseasesHemic and Lymphatic DiseasesLymphoproliferative DisordersLymphatic DiseasesImmunoproliferative DisordersImmune System Diseases

Study Officials

Kirsten Ness, PhD
St. Jude Children's Research Hospital
PRINCIPAL INVESTIGATOR
Deo Srivastava, PhD
St. Jude Children's Research Hospital
PRINCIPAL INVESTIGATOR
Lisa Jacola, PhD, ABPP-CN2
St. Jude Children's Research Hospital
PRINCIPAL INVESTIGATOR
Rachel Webster, PhD
St. Jude Children's Research Hospital
PRINCIPAL INVESTIGATOR

Enrollment

125 participants (actual enrollment reported by the registry).

Study Design

Study Type: observational
Observational Model: OTHER
Time Perspective: PROSPECTIVE
Sponsor Type: OTHER
Responsible Party: SPONSOR

Study Record Dates

First Submitted

February 22, 2023

First Posted

March 10, 2023

Study Start

March 22, 2023

Actual (reported)

Childhood Cancer Survivors' Affective Response to Exercise

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

First Submitted

First Posted

Study Start

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (2)

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

First Submitted

First Posted

Study Start

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (2)

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations